These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1486120)

  • 1. Positron emission tomography, the best available standard for viable myocardium: a "wealthy" tool for what?
    Parodi O
    J Nucl Biol Med (1991); 1992; 36(3):267-72. PubMed ID: 1486120
    [No Abstract]   [Full Text] [Related]  

  • 2. [Positron emission tomography (PET)].
    Tamaki N; Morita K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():377-86. PubMed ID: 12735002
    [No Abstract]   [Full Text] [Related]  

  • 3. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
    Schelbert HR
    J Nucl Med; 1992 Jul; 33(7):1263-6. PubMed ID: 1613562
    [No Abstract]   [Full Text] [Related]  

  • 4. Positron emission tomography for the assessment of myocardial viability.
    Schelbert HR
    Circulation; 1991 Sep; 84(3 Suppl):I122-31. PubMed ID: 1884478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography in the diagnosis and management of coronary artery disease.
    Bratton NG
    J La State Med Soc; 1995 May; 147(5):193-6. PubMed ID: 7782672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of viable, ischemic myocardium by positron-emission tomography with 11C-palmitate.
    Lerch RA; Ambos HD; Bergmann SR; Welch MJ; Ter-Pogossian MM; Sobel BE
    Circulation; 1981 Oct; 64(4):689-99. PubMed ID: 6974061
    [No Abstract]   [Full Text] [Related]  

  • 7. [Positron computed tomography of the heart].
    Yoshida K; Masuda Y; Yamazaki T; Tateno Y
    Kokyu To Junkan; 1984 Mar; 32(3):241-8. PubMed ID: 6610906
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of dilated cardiomyopathy and coronary artery disease using positron CT (PCT)].
    Fudo T; Kambara H; Hashimoto T; Hayashi M; Kawai C
    Kokyu To Junkan; 1988 Jun; 36(6):649-53. PubMed ID: 3265217
    [No Abstract]   [Full Text] [Related]  

  • 9. Positron-emission tomography: assessment of myocardial blood flow and metabolism.
    Schelbert HR
    Circulation; 1985 Nov; 72(5 Pt 2):IV122-33. PubMed ID: 3902283
    [No Abstract]   [Full Text] [Related]  

  • 10. [Identification of viable myocardium: current goal in ischemic heart disease with ventricular dysfunction].
    Marin-Neto JA; Bonow RO
    Arq Bras Cardiol; 1991 Jul; 57(1):1-3. PubMed ID: 1823754
    [No Abstract]   [Full Text] [Related]  

  • 11. Positron emission tomography versus thallium-201 scintigraphy for assessment of viable myocardium.
    Bonow RO
    J Nucl Biol Med (1991); 1992; 36(2 Suppl):122-5. PubMed ID: 1450234
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical role of positron emission tomography for cardiology in the 1990s and beyond.
    Goldstein RA; Willerson JT
    J Nucl Med; 1991 Apr; 32(4):606-9. PubMed ID: 2013800
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of positron emission tomography in the heart. Council on Scientific Affairs. Report of the Positron Emission Tomography Panel.
    JAMA; 1988 Apr 22-29; 259(16):2438-45. PubMed ID: 3280846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of the heart with positron emission tomography.
    Bergmann SR
    Am J Card Imaging; 1994 Apr; 8(2):181-8. PubMed ID: 8032190
    [No Abstract]   [Full Text] [Related]  

  • 15. Imaging to distinguish between viable and nonviable myocardium: pathophysiologic basis and importance of positron emission tomography.
    Gropler RJ
    AJR Am J Roentgenol; 1993 Sep; 161(3):497-500. PubMed ID: 8352093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ischemic myocardial injury evaluated using positron emission tomography in children with coronary artery disease: comparison with thallium-201 SPECT].
    Yoshibayashi M; Tamaki N; Nishioka K; Matsumura M; Yonekura Y; Yamashita K; Konishi J; Ban T; Mikawa H
    J Cardiol; 1992; 22(1):21-6. PubMed ID: 1307567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future directions for clinical investigation of the heart with positron-emission tomography.
    Selwyn AP; Smith TW
    Circulation; 1985 Nov; 72(5 Pt 2):IV31-8. PubMed ID: 3876892
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical role of metabolic imaging of the heart by positron emission tomography.
    Schwaiger M; Hicks R
    J Nucl Med; 1991 Apr; 32(4):565-78. PubMed ID: 2013798
    [No Abstract]   [Full Text] [Related]  

  • 19. [The value of positron emission tomography (PET) in cardiologic diagnosis].
    Henze E
    Internist (Berl); 1990 May; 31(5):338-40. PubMed ID: 2380010
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiac positron emission tomography--current status and future perspectives].
    Armbrecht JJ; Schelbert HR
    Z Kardiol; 1990 Mar; 79(3):151-60. PubMed ID: 2191506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.